CHARLES RIVER LABORATORIES (CRL) Stock Earnings & Estimates
USA - NYSE:CRL - US1598641074 - Common Stock
170.91 USD
+1.94 (+1.15%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.976B 12.31% | 4.129B 3.86% | 4.05B -1.92% | 4.031B -0.47% | 4.129B 2.43% | 4.34B 5.11% | 4.528B 4.33% | 4.591B 1.39% | 4.903B 6.80% | 5.154B 5.12% | 5.425B 5.26% | |
| EBITDA YoY % growth | 963.585M 7.24% | 973.446M 1.02% | 912.573M -6.25% | 1.027B 12.54% | 1.067B 3.89% | 1.144B 7.22% | 1.195B 4.46% | 1.286B 7.62% | 1.286B | 1.376B 7.00% | 1.485B 7.92% | |
| EBIT YoY % growth | 659.715M 4.22% | 659.322M -0.06% | 550.832M -16.45% | 771.81M 40.12% | 792.36M 2.66% | 844.61M 6.59% | 932.89M 10.45% | 968.77M 3.85% | N/A | N/A | N/A | |
| Operating Margin | 16.59% | 15.97% | 13.60% | 19.15% | 19.19% | 19.46% | 20.60% | 21.10% | N/A | N/A | N/A | |
| EPS YoY % growth | 11.13 7.74% | 10.65 -4.31% | 10.32 -3.10% | 10.29 -0.31% | 10.88 5.71% | 11.85 8.94% | 13.14 10.88% | 14.09 7.28% | 14.11 0.12% | 29.52 109.23% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.37 -11.03% | 2.59 10.63% | 2.86 -8.34% | 2.67 9.82% | 2.73 15.16% | 2.80 8.08% | 2.87 0.26% | 2.96 10.97% | 3.02 10.64% |
| Revenue Q2Q % growth | 996.34M -0.62% | 1.009B 2.52% | 1.046B 1.34% | 1.018B 1.31% | 1.024B 2.78% | 1.061B 5.15% | 1.08B 3.25% | 1.085B 6.58% | 1.1B 7.42% |
| EBITDA Q2Q % growth | 236.32M -47.71% | 254.95M 16.48% | 274.76M -26.18% | 245.82M -48.37% | 273M 15.52% | 257.46M 0.98% | 262.31M -4.53% | 270.78M 10.15% | 310.73M 13.82% |
| EBIT Q2Q % growth | 182.24M 102.04% | 198.04M 101.03% | 212.12M 60.29% | 165.38M 9.46% | 180.58M -0.91% | 178.11M -10.06% | 183.4M -13.54% | 179.41M 8.48% | 175.16M -3.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.43 -6.18% | 2.36 | 0.07 | 2.88% |
| Q2 2025 Q2Q % growth | 3.12 11.43% | 2.52 | 0.60 | 23.68% |
| Q1 2025 Q2Q % growth | 2.34 3.08% | 2.10 | 0.24 | 11.44% |
| Q4 2024 Q2Q % growth | 2.66 8.13% | 2.56 | 0.10 | 4.03% |
| Q3 2024 Q2Q % growth | 2.59 -4.78% | 2.45 | 0.14 | 5.70% |
| Q2 2024 Q2Q % growth | 2.80 4.09% | 2.42 | 0.38 | 15.80% |
| Q1 2024 Q2Q % growth | 2.27 -18.35% | 2.09 | 0.18 | 8.63% |
| Q4 2023 Q2Q % growth | 2.46 -17.45% | 2.43 | 0.03 | 1.38% |
| Q3 2023 Q2Q % growth | 2.72 3.42% | 2.39 | 0.33 | 13.71% |
| Q2 2023 Q2Q % growth | 2.69 -2.89% | 2.66 | 0.03 | 0.95% |
| Q1 2023 Q2Q % growth | 2.78 1.09% | 2.61 | 0.17 | 6.34% |
| Q4 2022 Q2Q % growth | 2.98 19.68% | 2.77 | 0.21 | 7.46% |
| Q3 2022 Q2Q % growth | 2.63 -2.59% | 2.52 | 0.11 | 4.37% |
| Q2 2022 Q2Q % growth | 2.77 6.13% | 2.76 | 0.01 | 0.30% |
| Q1 2022 Q2Q % growth | 2.75 8.70% | 2.74 | 0.01 | 0.26% |
| Q4 2021 Q2Q % growth | 2.49 4.18% | 2.46 | 0.03 | 1.35% |
| Q3 2021 Q2Q % growth | 2.70 15.88% | 2.60 | 0.10 | 3.70% |
| Q2 2021 Q2Q % growth | 2.61 65.19% | 2.40 | 0.21 | 8.57% |
| Q1 2021 Q2Q % growth | 2.53 37.50% | 2.21 | 0.32 | 14.27% |
| Q4 2020 Q2Q % growth | 2.39 18.91% | 2.13 | 0.26 | 12.40% |
| Q3 2020 Q2Q % growth | 2.33 37.87% | 1.82 | 0.51 | 28.20% |
| Q2 2020 Q2Q % growth | 1.58 -3.07% | 1.28 | 0.30 | 23.72% |
| Q1 2020 Q2Q % growth | 1.84 31.43% | 1.50 | 0.34 | 22.89% |
| Q4 2019 Q2Q % growth | 2.01 | 1.85 | 0.16 | 8.48% |
| Q3 2019 Q2Q % growth | 1.69 | 1.65 | 0.04 | 2.50% |
| Q2 2019 Q2Q % growth | 1.63 | 1.57 | 0.06 | 3.90% |
| Q1 2019 Q2Q % growth | 1.40 | 1.40 | 0.00 | 0.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.005B -0.49% | 1.001B | 3.852M | 0.38% |
| Q2 2025 Q2Q % growth | 1.032B 0.59% | 994.91M | 37.225M | 3.74% |
| Q1 2025 Q2Q % growth | 984.168M -2.71% | 951.39M | 32.778M | 3.45% |
| Q4 2024 Q2Q % growth | 1.003B -1.08% | 993.46M | 9.089M | 0.91% |
| Q3 2024 Q2Q % growth | 1.01B -1.64% | 985.77M | 23.993M | 2.43% |
| Q2 2024 Q2Q % growth | 1.026B -3.19% | 1.035B | -8.883M | -0.86% |
| Q1 2024 Q2Q % growth | 1.012B -1.73% | 1.002B | 9.56M | 0.95% |
| Q4 2023 Q2Q % growth | 1.013B -7.85% | 1.001B | 12.476M | 1.25% |
| Q3 2023 Q2Q % growth | 1.027B 3.79% | 1.011B | 15.623M | 1.55% |
| Q2 2023 Q2Q % growth | 1.06B 8.92% | 1.064B | -4.063M | -0.38% |
| Q1 2023 Q2Q % growth | 1.029B 12.63% | 996.21M | 33.163M | 3.33% |
| Q4 2022 Q2Q % growth | 1.1B 21.52% | 1.045B | 54.843M | 5.25% |
| Q3 2022 Q2Q % growth | 989.157M 10.40% | 980.14M | 9.017M | 0.92% |
| Q2 2022 Q2Q % growth | 973.131M 6.40% | 1.005B | -31.869M | -3.17% |
| Q1 2022 Q2Q % growth | 913.929M 10.83% | 919.21M | -5.281M | -0.57% |
| Q4 2021 Q2Q % growth | 905.05M 14.42% | 897.16M | 7.89M | 0.88% |
| Q3 2021 Q2Q % growth | 895.937M 20.54% | 912.23M | -16.293M | -1.79% |
| Q2 2021 Q2Q % growth | 914.607M 33.99% | 889.25M | 25.357M | 2.85% |
| Q1 2021 Q2Q % growth | 824.6M 16.62% | 806.16M | 18.44M | 2.29% |
| Q4 2020 Q2Q % growth | 791M 14.46% | 764.43M | 26.57M | 3.48% |
| Q3 2020 Q2Q % growth | 743.3M 11.27% | 724.05M | 19.25M | 2.66% |
| Q2 2020 Q2Q % growth | 682.6M 3.80% | 645.71M | 36.89M | 5.71% |
| Q1 2020 Q2Q % growth | 707.1M 16.95% | 697.6M | 9.5M | 1.36% |
| Q4 2019 Q2Q % growth | 691.1M | 692.17M | -1.07M | -0.15% |
| Q3 2019 Q2Q % growth | 668M | 679.76M | -11.76M | -1.73% |
| Q2 2019 Q2Q % growth | 657.6M | 669.14M | -11.54M | -1.72% |
| Q1 2019 Q2Q % growth | 604.6M | 601.62M | 2.98M | 0.50% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.35% | -1.61% | -0.03% | 6.11% |
| Revenue | 0.38% | 3.17% | 0.1% | 2.36% |